Yulangsan MHBFC reversed cardiac remodeling and protected against myocardial damage in rats by activating the eNOS-NO signaling pathway and counteracting MMVEC apoptosis.
Does Yulangsan MHBFC reverse cardiac remodeling in rats?
Yulangsan MHBFC demonstrates cardioprotective effects and reverses cardiac remodeling in a rat model via activation of the eNOS-NO signaling pathway.
Absolute Event Rate: 0% vs 0%
K and Akt protein phosphorylation, and activated the eNOS-NO signaling pathway, increased eNOS enzyme activity, catalyzed the generation of protective NO, and counteracted MMVEC apoptosis induced by cardiac remodeling, thereby protecting against myocardial damage and reversing cardiac remodeling.
Ye et al. (Wed,) reported a other. Yulangsan MHBFC reversed cardiac remodeling and protected against myocardial damage in rats by activating the eNOS-NO signaling pathway and counteracting MMVEC apoptosis.